rs58542926, TM6SF2

N. diseases: 42
Disease: Hepatitis C, Chronic ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.040 GeneticVariation BEFREE In conclusion, the TM6SF2 E167K variant promotes the development of steatosis, fibrosis and cirrhosis in patients with chronic hepatitis C. Conversely, this variant reduces circulating atherogenic lipid fractions. 28839198 2017
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.040 GeneticVariation BEFREE TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C. 26259026 2016
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.040 GeneticVariation BEFREE Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients. 25820484 2015
Hepatitis C, Chronic
CUI: C0524910
Disease: Hepatitis C, Chronic
0.040 GeneticVariation BEFREE This is the first demonstration that TM6SF2 E167K variant is an independent predictor of liver steatosis in chronic hepatitis C. 25581573 2015